ConsultBot: An improved tool for arterial blood gas analysis based on generative AI modeling
In partnership with Amazon Web Services (AWS), Praveen Meka, MD, in-patient hospitalist at Dana-Farber has developed the first version of ConsultBot — a generative AI diagnostic tool for easy-to-use analysis and faster clinical interpretation of arterial blood gas results while lowering the risk of missing or incorrect identification of complex disorders. Read more.
Blavatnik Harvard Life Lab Welcomes Applications from Potentially High-Impact Harvard-affiliated Startups
At just over a year old, the Blavatnik Harvard Life Lab housed on the Harvard Medical School campus is the host of eight start-up companies affiliated with Harvard and its affiliated hospitals and research communities, including Dana-Farber. PreDICTA Biosciences, which has evolved from the Dana-Farber laboratories of Irene Ghobrial, MD, Ken Anderson, MD, PhD, and Romanos Sklavenitis-Pistofidis, MD, PhD, and others, will be the newest company to take up residence at the Life Lab this summer, which has now surpassed 65% occupancy.
The lab is actively looking for new teams in its current application round, in which teams will pitch live to the Selection Committee on April 26. Interested applications are invited to an Open House and tour on March 27, from 1-3PM. RSVP here. The application round will close on April 12. Use this link to submit an application for residency.
Read more about the mission and supports available at the Blavatnik Harvard Life Lab.
Bayer’s Expert Mondays Knowledge Sharing for Innovators Webinar Series
Are you a Dana-Farber pre-seed or seed innovator or entrepreneur in oncology, cell & gene therapy, cardiovascular, immunology, radiology, or digital health?
Join Bayer´s Expert Mondays – 13-webinar session to gain valuable insights from industry leaders on topics around Regulatory, EU Innovation Legislation, Cell & Gene specifics, how to master the art of pitching, how big pharma is evaluating collaboration offers, how to approach VCs, and more.
The webinars are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities. The next session, Cell & Gene Market Access Planning Differences in EMEA & US, is scheduled for April 22, 2024, featuring Bayer’s Dr. Markus Frick, Global Market Access Lead, Cell & Gene. Check out all topics and register here.
MassBio State of Possible April Conferences Open for Registration
Our partner, MassBio, is sponsoring two conferences in April. The annual 2024 State of Possible Conference scheduled for April 24, 2024 will feature speakers from the Massachusetts life sciences research community. This year’s theme – Meeting the Moment – reflects progress made on longtime unmet needs and delivering for patients despite challenges to innovation.
On April 25, the MassBio Align Summit will focus on artificial intelligence and machine learning in drug discovery and development. The day will include 50 presentations on two tracks – seed to Series A biotech companies and emerging companies focused on AI/ML R&D – along with all-day partnering opportunities.
Entrepreneurial Female Scientists Are Invited to the Science to the Street Translational Research Symposium
Dana-Farber female scientists who are ready to bring their discoveries to market are invited to attend the next Science to the Street Translational Research Symposium on April 18, 2024 in New York.
Join a community of like-minded scientists and hear from featured speakers about the path to commercialization. Keynote speaker, Shana Kelley, President of the Chan Zuckerberg Biohub in Chicago and Professor of Chemistry and Biomedical Engineering at Northwestern University, will discuss her journey in building life-science startups and lessons learned. RSVP for this free event sponsored by Advancium Health Network.
From the Dana-Farber Newsroom
Links to stories, news announcements, and podcasts on innovative research from the DFCI research community
Dana-Farber Cancer Institute researchers join global Cancer Grand Challenges team taking on solid tumors in children
Dana-Farber Cancer Institute’s Scott Armstrong, MD, PhD, Benjamin Ebert, MD, PhD, Eric Fischer, PhD, Cigall Kadoch, PhD, and Kimberly Stegmaier, MD, are part of a global, interdisciplinary team of researchers, called Team PROTECT, that has been selected to receive a Cancer Grand Challenges award. The award, of up to $25 million over five years, will be used to tackle solid tumors in children.
Read the full story here.